Loading stock data…
Sotera Health Company (SHC)
$17.52+0.14 (+0.81%)
Market ClosedLast close Jun 29
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Sotera Health Company in the Healthcare sector is trading at $17.52 with a market capitalization of $5.0B. Wall Street consensus targets $20.22 (9 analysts), implying a +15.4% move over the next 12 months. The stock is currently 12% below its 52-week high of $19.85, remaining 7.7% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +15.4% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $280.05M↓ | $303.44M↓ | $311.31M↑ | $294.34M↑ | $254.52M |
| Gross Profit | $147.07M↓ | $165.92M↓ | $177.56M↑ | $166.62M↑ | $135.43M |
| Operating Income | $75.83M↓ | $105.38M↓ | $111.18M↑ | $88.43M↑ | $57.04M |
| Net Income | $26.59M↓ | $34.85M↓ | $48.40M↑ | $7.96M↑ | -$13.26M |
Peer Comparison
JNJUNHPFE
Fundamentals
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and N...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$5.00B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
42.73
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.80
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
18.92%
Volume
Today's trading volume
2.38M
Recent News
Is Sotera Health Company (SHC) A Good Stock To Buy Now?
Is SHC a good stock to buy? We came across a bullish thesis on Sotera Health Company on Valueinvestorsclub.com by AZA0601. In this article, we will summarize the bulls’ thesis on SHC. Sotera Health Company’s share was trading at $17.10 as of June 25th. SHC’s trailing and forward P/E were 41.71 and 17.27 respectively according to Yahoo […]
1 Healthcare Stock for Long-Term Investors and 2 We Turn Down
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destocking have persisted in the wake of COVID-19, limiting growth. This has capped returns as the industry’s six-month gain of 7.7% has lagged the S&P 500’s 9.3% climb.
Tesla upgraded, Lululemon downgraded: Wall Street's top analyst calls
Tesla upgraded, Lululemon downgraded: Wall Street's top analyst calls
1 Cash-Producing Stock Worth Your Attention and 2 That Underwhelm
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
3 Stocks Estimated To Be Trading Up To 44.8% Below Intrinsic Value
The United States market has shown robust performance, climbing 1.2% in the last week and 29% over the past year, with earnings projected to grow by 17% annually. In such an environment, identifying stocks that are trading below their intrinsic value can present opportunities for investors seeking potential growth at a reasonable price.